Azora Therapeutics, Inc. (DE) (AZR) Cash & Equivalents (2017 - 2026)
Azora Therapeutics, Inc. (DE) (AZR) recorded Cash & Equivalents of $22.04 million in Q3 2026, up 378.5% from $4.61 million a year earlier but down 23.2% from the prior quarter.
Powered by 
Analysis
Azora Therapeutics, Inc. (DE) (AZR) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Azora Therapeutics, Inc. (DE) reported Cash & Equivalents of $5.88 million, up 56.8% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 6.0% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $3.75 million in FY2024 (+32.7%), $2.83 million in FY2023 (-29.4%), $4 million in FY2022 (-34.0%) and $6.06 million in FY2021 (+37.7%).
- Quarterly Cash & Equivalents has ranged from $315,880 in Q3 2023 to $28.71 million in Q2 2026 over the past five years.
- On a year-over-year basis, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 120.3% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 385.4% in Q2 2026, against a decline of 94.5% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $28.71 million (Q2 2026), $4.58 million (Q1 2026) and $5.88 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Azora Therapeutics, Inc. (DE) | 58.43 Mn | -2.79 Mn | - | 22.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 22.04 Mn |
| Jun 30, 2026 | 28.71 Mn |
| Mar 31, 2026 | 4.58 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Sep 30, 2025 | 4.61 Mn |
| Jun 30, 2025 | 5.92 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 3.75 Mn |
| Sep 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | 3.29 Mn |
| Mar 31, 2024 | 5.03 Mn |
| Dec 31, 2023 | 2.83 Mn |
| Sep 30, 2023 | 315,880.00 |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 2.31 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 5.75 Mn |
| Jun 30, 2022 | 9.16 Mn |
| Mar 31, 2022 | 12.69 Mn |
| Dec 31, 2021 | 6.06 Mn |
API Access
Azora Therapeutics, Inc. (DE) Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AZR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AZR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AZR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();